1887

Chapter 10 : Severe Legionnaires’ Disease Successfully Treated with Levofloxacin and Azithromycin

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Abstract:

Fluoroquinolones are the most active drugs against in intracellular and animal models, achieving high intracellular levels and low MICs. In patients with human immunodeficiency virus infection, Legionnaires' disease (LD) has a more severe clinical presentation and worse evolution, with a mortality rate of up to 20%. This chapter presents a case of a severely inmunosuppressed woman with LD in whom treatment failed with levofloxacin and who recovered after the addition of azithromycin. The intracellular location of the pathogen is relevant to the efficacy of the antibiotic. At present, new macrolides such as clarithromycin and azithromycin and fluoroquinolones are the most active drugs in the treatment of pneumonia. Even though the advances in rapid specific diagnosis and the greater efficacy of the new macrolides and quinolones have led to a better prognosis of pneumonia, mortality continues to be very high in immunosuppressed patients. Thus, randomized trials comparing the efficacy of combination therapies with new macrolides and quinolones versus monotherapy should be performed to evaluate their real impact in reducing morbidity and mortality of pneumonia with bad prognostic factors.

Citation: Pedro-Botet M, Sopena N, Tural C, García-Cruz A, Mateu L, Ragull S, García-Núñez M, Roure S, Rey-Joly C, Sabrià M. 2006. Severe Legionnaires’ Disease Successfully Treated with Levofloxacin and Azithromycin, p 40-42. In Cianciotto N, Kwaik Y, Edelstein P, Fields B, Geary D, Harrison T, Joseph C, Ratcliff R, Stout J, Swanson M (ed), . ASM Press, Washington, DC. doi: 10.1128/9781555815660.ch10

Key Concept Ranking

Highly Active Antiretroviral Therapy
0.53392625
0.53392625
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555815660.ch10

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error